Embleema offers a data and bioinformatics platform that integrates molecular, clinical, and real-world data to produce insights for personalized medicine. The platform provides tools for participant recruitment, data collection, and regulatory submissions.

Embleema

Hippo Research incentivizes patients to share medical data for research and development purposes, utilizing blockchain technology to protect privacy.

Hippo Research

MediBloc Limited is developing a patient-centered health data ecosystem that protects individual privacy and enhances the reliability of health data through a blockchain-based platform called ‘Panacea’.

MediBloc Limited

Medicalchain uses blockchain technology to securely manage health records, aiming to give patients control over their medical data and facilitate sharing within their medical network. The company self-describes its solution as collaborative and efficient for healthcare.

Metric
Company Name	Embleema	Hippo Research	MediBloc Limited	Medicalchain
Symbol
MSH ID	COM:EMBLEEMA	AU:COM:HIPPORESEARCH	COM:MEDIBLOC	COM:MEDICALCHAIN
Market	PRIVATE	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services
Industry	Biotechnology	Health Technology	Health Technology	Health Information Technology
Country	US	AU	KR	FR
Stage			Venture Round	Initial Coin Offering
Employee Count
Website	embleema.com	hipporesearch.com.au	medibloc.com	medicalchain.com
LinkedIn
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic				664
Web Traffic Growth				-0.79
Valuation
Raised Capital				24M

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

EMBL

COM:EMBLEEMA

Embleema

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue